Elixinol Wellness Ltd (ASX: EXL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Elixinol Wellness Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$7.80 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
1.32 billion
Earnings per share
-0.008
Dividend per share
N/A
Year To Date Return
-46.43%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Elixinol Wellness Ltd (ASX: EXL)
Latest News
Retail Shares
Soft spending: How ASX retail shares are responding to a weak month
Cannabis Shares
Blazing it? How the top ASX cannabis shares performed in FY21
Cannabis Shares
Elixinol (ASX:EXL) share price heats up on cannabis business update
Cannabis Shares
Here's why ASX cannabis shares are lighting up today
Share Market News
Why ASX hemp share Elixinol's (ASX:EXL) share price is moving higher
Share Market News
Why the Elixinol (ASX:EXL) share price has been halted today?
Share Market News
Up in smoke! Why ASX cannabis shares are having a bleary day
Share Fallers
Why Elixinol Global, Flight Centre, Mesoblast, & WiseTech shares are dropping lower
Share Market News
Why the Elixinol Global (ASX:EXL) share price is getting smoked today
Share Market News
27 ASX companies just got an unwanted knock on the door
Share Market News
Elixinol (ASX:EXL) share price tumbles on capital raising update
Share Market News
Why the Elixinol (ASX:EXL) share price popped 43% today
EXL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Elixinol Wellness Ltd
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the three operating segments of the Americas, Australia, Rest of the World regions of which key revenue is derived from the Australia segment. The Australia segment includes the results from operations of Elixinol Wellness (Byron Bay) Pty Ltd and The Sustainable Nutrition Group Pty Ltd and its subsidiaries.
EXL Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 22 Nov 2024 | $0.01 | $0.00 | 0.00% | 3,851,169 | $0.01 | $0.01 | $0.01 |
| 21 Nov 2024 | $0.01 | $0.00 | 0.00% | 733,614 | $0.01 | $0.01 | $0.01 |
| 20 Nov 2024 | $0.01 | $0.00 | 0.00% | 16,942,535 | $0.01 | $0.01 | $0.01 |
| 19 Nov 2024 | $0.01 | $0.00 | 0.00% | 321,336 | $0.01 | $0.01 | $0.01 |
| 18 Nov 2024 | $0.01 | $0.00 | 0.00% | 8,867,028 | $0.01 | $0.01 | $0.01 |
| 15 Nov 2024 | $0.01 | $0.00 | 0.00% | 10,226,428 | $0.01 | $0.01 | $0.00 |
| 14 Nov 2024 | $0.00 | $0.00 | 0.00% | 10,354,901 | $0.00 | $0.00 | $0.00 |
| 13 Nov 2024 | $0.00 | $0.00 | 0.00% | 107,650 | $0.00 | $0.00 | $0.00 |
| 12 Nov 2024 | $0.00 | $0.00 | 0.00% | 19,247 | $0.00 | $0.00 | $0.00 |
| 11 Nov 2024 | $0.00 | $0.00 | 0.00% | 1,460,087 | $0.00 | $0.00 | $0.00 |
| 07 Nov 2024 | $0.00 | $0.00 | 0.00% | 1,404,496 | $0.00 | $0.00 | $0.00 |
| 06 Nov 2024 | $0.00 | $0.00 | 0.00% | 146,731 | $0.00 | $0.00 | $0.00 |
| 05 Nov 2024 | $0.00 | $0.00 | 0.00% | 309,868 | $0.00 | $0.00 | $0.00 |
| 04 Nov 2024 | $0.00 | $0.00 | 0.00% | 550,584 | $0.00 | $0.00 | $0.00 |
| 01 Nov 2024 | $0.00 | $0.00 | 0.00% | 570,128 | $0.00 | $0.00 | $0.00 |
| 31 Oct 2024 | $0.00 | $0.00 | 0.00% | 30,551 | $0.00 | $0.00 | $0.00 |
| 30 Oct 2024 | $0.00 | $0.00 | 0.00% | 4,878,868 | $0.00 | $0.00 | $0.00 |
| 28 Oct 2024 | $0.00 | $0.00 | 0.00% | 296,053 | $0.00 | $0.00 | $0.00 |
| 25 Oct 2024 | $0.00 | $0.00 | 0.00% | 485 | $0.00 | $0.00 | $0.00 |
| 24 Oct 2024 | $0.00 | $0.00 | 0.00% | 2,507,927 | $0.00 | $0.01 | $0.00 |
| 23 Oct 2024 | $0.00 | $0.00 | 0.00% | 1,345,491 | $0.00 | $0.00 | $0.00 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 31 May 2024 | David (Dave) Fenlon | Issued | 3,752,345 | $19,999 |
Director remuneration. 4,218,098 rIGHTS
|
| 08 Apr 2024 | Natalie Butler | Exercise | 874,000 | $5,244 |
Conversion of securities. 874,000 performance rights
|
| 08 Apr 2024 | Natalie Butler | Issued | 874,000 | $5,244 |
Conversion of securities.
|
| 28 Mar 2024 | Ron Dufficy | Expiry | 3,171,994 | $15,859 |
As advised by the company. Lapsed
|
| 28 Mar 2024 | David (Dave) Fenlon | Expiry | 1,250,000 | $6,250 |
As advised by the company. 465,753 Rights, lapsed
|
| 06 Feb 2024 | Ron Dufficy | Expiry | 548,077 | $5,480 |
As advised by the company. Lapsing of Performance Share rights,31,71,994 Rights
|
| 23 Nov 2023 | David (Dave) Fenlon | Issued | 625,000 | $8,750 |
Issue of options.
|
| 23 Nov 2023 | David (Dave) Fenlon | Exercise | 625,000 | $8,750 |
Conversion of securities. 17,15,753 Rights
|
| 23 Nov 2023 | David (Dave) Fenlon | Issued | 625,000 | $8,750 |
Conversion of securities.
|
| 23 Nov 2023 | Ron Dufficy | Issued | 902,778 | $12,638 |
Conversion of securities.
|
| 23 Nov 2023 | Ron Dufficy | Buy | 902,778 | $12,638 |
Issue of options.
|
| 23 Nov 2023 | Ron Dufficy | Exercise | 902,778 | $12,638 |
Conversion of securities. 37,20,071 Rights
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr David (Dave) Fenlon | Non-Executive DirectorNon-Executive Chairman | Mar 2022 |
Mr David has worked with retail brands both in Australia and offshore, with a focus on strategic planning and business transformation including in key positions with Tesco throughout Europe and Safeway in the UK. David was a member of the Board of Directors for the Special Olympics from May 2017 until June 2019. Fenlon has over 30 years of experience in the FMCG and consumer sectors. He is member of Risk Committee.
|
| Ms Pauline Therese Gately | Non-Executive Director | Aug 2023 |
Ms Gately is a director who brings a commercial focus to strategy with demonstrated achievement in funding, business development, and strategic transformation having led companies through IPO, business recalibration and mergers and acquisitions. Her Board contributions are also underpinned by senior roles in international investment banking across the Asia Pacific region. She is chair of Risk Committee.
|
| Ms Natalie Butler | Non-Executive Director | Mar 2024 |
--
|
| Ms Melanie Jaye Leydin | Company Secretary | Jul 2024 |
-
|
| Melanie Jaye Leydin | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Cg Nominees (Australia) Pty Ltd | 31,074,072 | 4.91% |
| UBS Nominees Pty Ltd | 20,945,417 | 3.31% |
| Hsbc Custody Nominees (Australia) Limited | 18,698,448 | 2.95% |
| Citicorp Nominees Pty Limited | 18,181,816 | 2.87% |
| Rosedale Super Pty Ltd (Rosedale Super Fund A/C) | 16,871,048 | 2.67% |
| Raw With Life Pty Ltd (Benhaim Trading A/C) | 16,692,881 | 2.64% |
| James Robert Hood Pty Ltd (Bluestone A/C) | 11,387,115 | 1.80% |
| Mr Stuart Reseck & Mrs Nicole Deanne Reseck (Reseck Super Fund A/C) | 11,000,000 | 1.74% |
| Ms Pauline Therese Gately | 9,930,583 | 1.57% |
| Interdale Pty Ltd (Maple Super A/C) | 7,035,496 | 1.11% |
| Mr Kieran John O'Brien | 6,021,500 | 0.95% |
| Mr Ashley Hardwick | 5,402,778 | 0.85% |
| Jasforce Pty Ltd | 5,049,873 | 0.80% |
| Mr Ronald Michael Dufficy | 4,814,835 | 0.76% |
| Bnp Paribas Nominees Pty Ltd Acf Clearstream | 4,539,590 | 0.72% |
| Cotton On Innovation Fund Pty Ltd | 4,472,461 | 0.71% |
| D & G Health Llc | 4,119,229 | 0.65% |
| Mr Nicky Alfred Kleyn | 4,000,000 | 0.63% |
| Kaneden Enterprises Pty Ltd (Roseburgh Family Super A/C) | 4,000,000 | 0.63% |
| Cotton On Innovation Fund Pty Ltd i | 3,928,750 | 0.62% |
